USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
The paper discusses the specific features of using nonsteroidal anti-inflammatory drugs in patients with high cardiovascular risk.
Saved in:
| Main Author: | Yu. A. Olyunin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2017-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW DATA ON THE SAFETY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE CONCEPT OF THE HIGH CLASS-SPECIFIC CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS IS OUTDATED
by: A. E. Karateev, et al.
Published: (2017-04-01) -
Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events?
by: E. V. Dovgan
Published: (2017-09-01) -
How effective is the average therapeutic dose of a nonsteroidal anti-inflammatory drug in osteoarthritis?
by: A. E. Karateev
Published: (2019-03-01) -
Cardiovascular effects and the use of nonsteroidal anti-inflammatory drugs
by: N. Schellack
Published: (2014-02-01) -
WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST?
by: Yu. V. Muravyev
Published: (2017-07-01)